drugset / Trial / NCT01122615
Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC)
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to find the highest tolerable dose of the combination of sunitinib and temsirolimus that can be given to patients with metastatic kidney cancer.
Timeline
- Start
- 2010-05
- Primary completion
- 2014-07
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sunitinib | Small molecule | — | Oral |
| Subject | Temsirolimus | Small molecule | — | Intravenous |